Read more
Nanostructured systems have the potential to revolutionize both preventive and therapeutic approaches for treating cardiovascular disease. Given the unique physical and chemical properties of nanostructured systems, nanoscience and nanotechnology have recently demonstrated the potential to overcome many of the limitations of cardiovascular medicine through the development of new pharmaceuticals, imaging reagents and modalities, and biomedical devices. A recent review offers an outline of critical issues and emerging developments in cardiac nanotechnology.
Read more
Summary: Researchers are testing a new vaccine and oral medication that could delay or prevent Alzheimer’s disease from developing in those with a genetic predisposition.
Source: Keck Medicine USC.
The Keck School of Medicine of USC launches a study exploring whether two different therapies can prevent a leading cause of death.
Read more
We are delighted to announce that the AgeMeter project has reached its initial funding goal and development of the device can now begin thanks to the support of the community. As a result, we will soon have a great aging biomarker system available to the healthcare professional and home enthusiast alike.
We would like to thank Longecity for running a matching fund and for making a big contribution to the project by purchasing an AgeMeter for their affiliate labs program. This means that their affiliated researchers will have access to an AgeMeter for their aging research in the near future and is another great example of how we as a community are helping support scientists working on the front lines.
So far two Longecity affiliates have already expressed an interest in using the AgeMeter:
Read more
